EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro

Hinako Koze, Masayuki Sudoh, Satoaki Onitsuka, Hiroaki Okamura, Takeshi Ishikawa, Fumito Tani, Yukako Miyata-Yabuki, Mikako Shirouzu, Masanori Baba, Mika Okamoto, Toshiyuki Hamada

Journal of Natural Medicines · 2025

DOI: 10.1007/s11418-024-01855-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Natural Medicines, 2025. Verfasst von Hinako Koze und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science and Engineering, Kagoshima University, 1-21-35 Korimoto, Kagoshima, 890-0065, Japan. Hauptthemen laut MEDLINE: SARS-CoV-2, Virus Replication, Antiviral Agents, Plant Extracts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kagoshima University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The persistence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the emergence of new mutant strains continue to present a substantial threat with potential for future pandemics. Safe, effective, and readily available COVID-19 therapeutics are urgently needed to prepare for future coronavirus pandemics. To help identify new antiviral agents, the present study focused on natural products in the extracts of Holy Basil, Ocimum tenuiflorum L., which show potential inhibitory effects against the SARS-CoV-2 main protease (M pro ). Bioassay-guided isolation of the MeOH extracts of O. tenuiflorum led to the identification of a sulfur-containing glyceroglycolipid, sulfoquinovosyl diacylglycerol (SQDG: 1 ), as a potent M pro inhibitor that effectively inhibited M pro activity (IC 50 : 0.42 µM). SQDG ( 1 ) also markedly suppressed SARS-CoV-2 replication (EC 50 , 51.2 µM) in vitro while displaying no cytotoxicity (CC 50 > 100 µM). Further inhibition kinetic studies and docking simulations clearly demonstrated that SQDG strongly inhibited SARS-CoV-2 M pro in a competitive and mixed-inhibition manner. These findings highlight SQDG as a promising lead compound for COVID-19 therapy and emphasize the need to explore new drugs from natural sources. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Virus ReplicationAntiviral AgentsPlant ExtractsCoronavirus 3C ProteasesOcimumOcimum basilicumHumansChlorocebus aethiopsCOVID-19 Drug TreatmentVero CellsCOVID-19Molecular Docking SimulationAnimals

Stichwörter der Autor:innen

Ocimum tenuiflorum L.Mpro inhibitorSARS-CoV-2 main proteaseSulfoquinovosyl diacylglycerol

Substanzen

Antiviral AgentsPlant ExtractsCoronavirus 3C Proteases

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Science and Engineering, Kagoshima University, 1-21-35 Korimoto, Kagoshima, 890-0065, Japan.
  • Faculty of Science, Kagoshima University, 1-21-35 Korimoto, Kagoshima, 890-0065, Japan.
  • Department of Translational Research, Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan.
  • Department of Chemistry, Biotechnology, and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima, 890-0065, Japan.
  • Institute for Materials Chemistry and Engineering, Kyushu University, 744 Motooka Nishi-ku, Fukuoka, 819-0395, Japan.
  • Drug Discovery Structural Biology Platform Unit, Center for Biosystems Dynamics Research, RIKEN, 1-7-22 Suehiro, Tsurumi, Yokohama, Kanagawa, 230-0045, Japan.

Förderung

  • Kagoshima University

Zitieren

APA

Koze, H., Sudoh, M., Onitsuka, S., Okamura, H., Ishikawa, T., Tani, F., Miyata-Yabuki, Y., Shirouzu, M., Baba, M., Okamoto, M., & Hamada, T. (2025). Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro. Journal of Natural Medicines. https://doi.org/10.1007/s11418-024-01855-6

Vancouver

Koze H, Sudoh M, Onitsuka S, Okamura H, Ishikawa T, Tani F, et al. Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro. Journal of Natural Medicines. 2025. doi:10.1007/s11418-024-01855-6

BibTeX
@article{Koze2025,
  author = {Koze, Hinako and Sudoh, Masayuki and Onitsuka, Satoaki and Okamura, Hiroaki and Ishikawa, Takeshi and Tani, Fumito and Miyata-Yabuki, Yukako and Shirouzu, Mikako and Baba, Masanori and Okamoto, Mika and Hamada, Toshiyuki},
  title = {Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro},
  journal = {Journal of Natural Medicines},
  year = {2025},
  doi = {10.1007/s11418-024-01855-6}
}
Kostenlos starten →